Tag Archives: Xarelto
Decision on Pradaxa Bleeding Lawsuit Multidistrict Litigation Expected Soon
Victims of alleged Pradaxa injuries are awaiting word on whether their lawsuits will be consolidated in a multidistrict litigation. According to a report from The Madison Record, so far just over two dozen Pradaxa bleeding lawsuits have been filed in federal courts throughout the U.S.
National Law Firms Calls for More FDA Action on Actos Bladder Cancer Threat
A national law firm is not satisfied with the way the U.S. Food & Drug Administration (FDA) has handled warnings regarding Actos (pioglitazone) bladder cancer risks. In a statement published today, Parker Waichman LLP called on the FDA to compel Takeda Pharmaceuticals, the maker of the type 2 diabetes drug, ...
Whistleblower Wins Retaliation Lawsuit
A whistleblower who reported misconduct at Canaveral National Seashore has won a retaliation ruling against the U.S. Department of Interior, Florida Today reports.
Study Suggests Hormonal Contraceptives Linked to Increased Brain Tumor Risk
A study of Danish women of reproductive age suggests that long-term use of hormonal contraceptives is associated with an increased risk of brain tumors.
First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January
The first trials involving lawsuits filed against DePuy Orthopaedics by recipients of its recalled ASR Hip Implants will begin later this year, and early next year. The first is slated to start on December 3, 2012 in state court in Las Vegas, Nevada. A second DePuy ASR hip implant lawsuit ...
Toxic Nano-Particles from Failing Metal-on-Metal Hip Replacements May Pose Long-Term Health Risks
According to a new study, failing metal-on-metal hip implants generate toxic nano-particles that release Cobalt 2+ ions, which not only cause inflammation in surrounding tissue, but have the potential to cause long-term damage to the genetic material of cells. According to a report published by Medicalxpress.com, this “genotoxicity” could ...
Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit
A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...
Crash Involving MTA Bus and Two Cars Injures 23
Police are investigating an accident in Brooklyn on Wednesday afternoon that injured 23 people, 3 of them critically, when a car was knocked into the path of an MTA bus.
Research Study Confirms Fracking as Cause of Ohio Earthquakes
Fracking operation near Poland Township, Ohio, activated a previously unknown fault in the, causing 77 earthquakes with magnitudes ranging from 1.0 to 3.0 in March 2014.Xarelto Manufacturer Leads Spending for Physicians’ Favor
The public-interest news organization ProPublica issued a new report that indicates manufacturers spent more in 2015 on physician payments for Xarelto than any other drug. These payments were not for research, but for things like consulting, meals, travel, promotional speaking, … Continue reading
Pretrial Proceedings Moving Forward in First Four Xarelto Bellwether Cases
In a recent court order, Judge Eldon Fallon, who oversees the Xarelto multidistrict litigation in the Eastern District of Louisiana, outlined the schedule for the first four trials. Judge Fallon has selected four cases to serve as the first bellwether … Continue reading
Xarelto Plaintiffs Hope for Outcome Similar to Pradaxa Settlement
The current multidistrict litigation (MDL) comprised of more than 7,000 Xarelto (rivoxaban) lawsuits filed against the Johnson & Johnson subsidiary, Janssen Pharmaceuticals, and Bayer AG is being overseen by the Honorable Judge Eldon E. Fallon in the Eastern District of … Continue reading
Xarelto Plaintiffs have More Time to File Lawsuits
Due to the number of Xarelto lawsuits that have flooded the clerk’s office, Judge Eldon Fallon has extended the filing deadline by 90 days. There are more than 7,000 lawsuits pending in the multidistrict litigation in the Eastern District of … Continue reading
In Xarelto MDL, Judge Extends Deadline to File Complaints
Certain groups of plaintiffs in the Xarelto multidistrict litigation (MDL) have more time to file a lawsuit against manufacturers Janssen Pharmaceuticals and Bayer Healthcare. According to a recent order issued by Judge Eldon Fallon, who is overseeing the MDL in … Continue reading
Quality of Xarelto Clinical Trials Expected to be an Issue in 2017 Court Cases
When the first lawsuits involving the blood-thinning drug Xarelto go to trial in 2017, attorneys expect the quality of the clinical trials involved in the drug’s approval to be a major issue. Xarelto lawsuits have been filed in both federal … Continue reading
Xarelto Lawsuits Continue to Mount, Clinical Trials Under Scrutiny
According to court records, Bayer AG and Janssen Pharmaceuticals are facing close to 6,000 lawsuits alleging that the companies failed to warn about the risks associated with Xarelto, an anti-coagulant drug. Plaintiffs in the litigation allege that the blood thinner … Continue reading
Bellwether Trial Dates in Xarelto Litigation Scheduled for 2017
Bellwether trial dates have been selected in the Xarelto multidistrict litigation (MDL) 2592. Court records show that more than 2,800 lawsuits have been consolidated into the MDL in Eastern Louisiana before U.S. District Judge Eldon E. Fallon. A list of … Continue reading
Lawsuit Alleges Eliquis Caused Fatal Hemorrhaging, Drug Makers Failed to Warn
Pfizer and Bristol-Myers Squibb are facing a wrongful death lawsuit alleging that the companies failed to warn about the risk of irreversible bleeding with Eliquis (apixaban), an anticoagulant. The lawsuit was filed on behalf of a woman whose husband began … Continue reading
Xarelto Led to Uncontrollable, Fatal Bleeding, Lawsuit Alleges
A woman in Vermont has filed a lawsuit alleging that her father suffered a fatal, uncontrollable brain bleed after taking the anticoagulant Xarelto. The lawsuit alleges that Bayer AG and Janssen Pharmaceuticals failed to warn about the risk of irreversible … Continue reading
